# US 2013/0252993 A1 · Tricyclic compound and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252993 A1
- Document ID: US20130252993A1
- Status: Published application
- Kind: A1
- Application number: 13/896,746
- Filed: 2013-05-17
- Published: 2013-09-26
- Earliest claimed: 2004-12-22
- Assignees: Ono Pharmaceutical Co., Ltd.
- Applicants: Ono Pharmaceutical Co., Ltd.
- Inventors: Kazuyuki OHMOTO; Masashi KATO; Yoshifumi KAGAMIISHI; Junichiro MANAKO
- Web page: https://patentgrep.com/patent/US20130252993A1

## CPC

- C07D 471/14: Ortho-condensed systems
- A61K 31/4375: the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A61K 31/438: The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 1/12: Antidiarrhoeals
- A61P 25/22: Anxiolytics
- A61P 25/24: Antidepressants
- A61P 37/02: Immunomodulators
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 471/04: Ortho-condensed systems
- C07D 471/10: Spiro-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to the compound represented by formula (I): (wherein, all the symbols have the same meaning as that of the specification), a salt thereof, a solvate thereof or a prodrug thereof. Since the compound of the present invention has an anti stress action, it is useful for preventive and/or therapeutic agent for a disease caused by stress, especially a digestive system disease caused by stress and is superior to oral absorption.

## Claims

### Claim 1

A compound represented by formula (I):
wherein R1 is a hydrogen atom(s) or a substituent(s),
t is 0 or an integer of 1 to 8, when t is 2 or more, R1s are same or different, two R1s may together form a cyclic group which may have a substituent(s);
R2, R3, R4, R5, R6 and R7 are each independently a hydrogen atom(s) or a substituent(s), R4 and R5 and/or R6 and R7 may form a cyclic group which may have a substituent(s) together with their binding carbon atom;
ring A1 is a monocyclic carbocyclic ring or a monocyclic heterocyclic ring;
ring A2 is a cyclic group which may have a substituent(s);
B is a hydrogen atom, a hydrocarbon group which may have a substituent(s) or a cyclic group which may have a substituent(s);
X and Z are each independently a bond, C1-3 alkylene which may have a substituent(s), C2-3 alkenylene which may have a substituent(s) or C2-3 alkynylene which may have a substituent(s);
Y is a bond, —C(═O)—, —C(═S)—, —C(═O)NR8—, —C(═S)NR8—, —SO2—, —C(═O)O— or —SO2NR8— group wherein X binds to a left side of each group,
R8 is a hydrogen atom or a substituent;
m is 0 or 1;
is a single bond or a double bond wherein 1) a and b are not a double bond at the same time, 2) when m is 0, b is a double bond, 3) when m is 1, b is a single bond,
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 2 (depends on 1)

The compound according to claim 1, wherein R4 and R5 form a cyclic group which may have a substituent(s) together with their binding carbon atom, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 3 (depends on 1)

The compound according to claim 1, wherein ring A1 is a monocyclic heterocyclic ring, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 4 (depends on 1)

The compound according to claim 1, wherein ring A1 is a monocyclic carbocyclic ring, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 5 (depends on 1)

The compound according to claim 1, wherein X is a bond, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 6 (depends on 1)

The compound according to claim 1, wherein Y is —C(═O)— or —C(═O)NR8— wherein X binds to a left side of each group, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 7 (depends on 1)

The compound according to claim 1, wherein Z is a bond or C1-3 alkylene which may have a substituent(s), a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 8 (depends on 1)

The compound according to claim 1, wherein B is C1-8 alkyl which may have a substituent(s), C3-10 monocyclic or bicyclic aromatic carbocyclic which may have a substituent(s), a carbocyclic ring which is partially or fully saturated, or 3-10 membered monocyclic or bicyclic aromatic heterocyclic ring which may be partially or fully saturated, and which contains 1 to 4 hetero atom(s) selected from an oxygen atom, a nitrogen atom and/or a sulfur atom, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 9 (depends on 1)

The compound according to claim 1, which is a compound represented by formula (I-A):
wherein all the symbols have the same meanings as described in claim 1, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 10 (depends on 1, 9)

The compound according to claim 9, which is a compound represented by formula (I-A-1):
wherein R1A has the same meaning as R1;
tB is 0 or an integer of 1 to 3, when tB is 2 or more, R1s are same or different;
other symbols have the same meanings as described in claim 1,
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 11 (depends on 1)

The compound according to claim 1, which is a compound represented by formula (I-B-1):
wherein tA is 0 or an integer of 1 to 4, when tA is 2 or more, R1s are same or different;
R4 and R5 form cyclic group which may have a substituent(s) together with their binding carbon atom;
other symbols have the same meanings as described in claim 1,
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 12 (depends on 1, 10)

The compound according to claim 1, which is a compound represented by formula (I-B-2):
wherein all symbols have the same meaning as described in claim 1 or 10,
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 13 (depends on 1, 11)

The compound according to claim 11, which is a compound represented by formula (I-B-1-1):
wherein B2 is C1-8 alkyl which may have a substituent(s);
D is an atom which constitutes ring A2 and is a carbon atom or a nitrogen atom,
is a cyclic group which has at least two same or different substituents;
other symbols have the same meanings as described in claim 1 or 11, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 14 (depends on 13)

The compound according to claim 13, wherein
is a cyclic group which has two same or different substituents, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 15 (depends on 14)

The compound according to claim 14,
wherein one substituent on ring A2 is (1) C1-8 alkoxy which may have a substituent(s), or (2) C3-7 cycloalkyloxy which may have a substituent(s);
the other substituent is selected from (1) a halogen atom, (2) cyano, (3) C1-8 alkyl which may have a substituent(s) and (4) C1-8 alkoxy which may have a substituent(s),
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 16 (depends on 15)

The compound according to claim 15,
wherein one substituent on ring A2 is selected from (1) methoxy which may have a fluorine atom(s), (2) isopropoxy which may have a fluorine atom(s), (3) cyclopentyloxy which may have a fluorine atom(s);
the other substituent is selected from (1) a fluorine atom, (2) a chlorine atom, (3) cyano, (4) methyl, and (5) methoxy which may have a fluorine atom(s),
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 17 (depends on 14)

The compound according to claim 14, wherein the cyclic group represented by
is a benzene ring, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 18 (depends on 13)

The compound according to claim 13, wherein one substituent is substituted to an atom neighboring D, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 19 (depends on 13)

The compound according to claim 13, which is a compound represented by formula (I-B-1-1-a):
wherein is β-configuration and other symbols have the same meanings as described in claim 13,
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 20 (depends on 11, 14)

The compound according to claim 14, which is a compound represented by formula (I-B-1-2):
wherein R201 is C1-8 alkoxy which may have a substituent(s) or C3-7 cycloalkyl which may have a substituent(s);
R202 is a halogen atom, cyano, C1-8 alkyl which may have a substituent(s) or C1-8 alkoxy which may have a substituent(s);
other symbols have the same meanings as described in claim 11,
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 21 (depends on 11, 19, 20)

The compound according to claim 20, which is a compound represented by formula (I-B-1-2-a):
wherein all symbols have the same meanings as described in claim 11, 19 or 20,
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 22 (depends on 20, 21)

The compound according to claim 20 or 21,
wherein R201 is selected from (1) methoxy which may have a fluorine atom(s), (2) isopropoxy which may have a fluorine atom(s), and (3) cyclopentyloxy which may have a fluorine atom(s);
R202 is selected from (1) a fluorine atom, (2) a chlorine atom, (3) cyano, (4) methyl, and (5) methoxy which may have a fluorine atom(s),
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 23 (depends on 1)

The compound according to claim 1, which is
(1) 1-(1,3-benzodioxol-5-yl)-N-(3,5-dimethylphenyl)-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(2) 2-acetyl-1-(2,4-difluorophenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(3) 2-acetyl-1-(3,4-difluorophenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(4) 2-acetyl-1-(3-fluorophenyl)-6-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(5) 2-acetyl-6-fluoro-1-(3-fluorophenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(6) 2-acetyl-1-(2,4-difluorophenyl)-6-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(7) 2-acetyl-1-(3,4-difluorophenyl)-6-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(8) 2-acetyl-1-(3-fluorophenyl)-7-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(9) 2-acetyl-7-fluoro-1-(3-fluorophenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(10) 2-acetyl-1-(3-fluorophenyl)-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(11) 1-(2,6-difluorophenyl)-N-(3,5-dimethylphenyl)-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(12) 1-(3,5-difluorophenyl)-N-(3,5-dimethylphenyl)-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(13) 1-(2,4-difluorophenyl)-N-(3,5-dimethyl-phenyl)-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(14) 1-(2,3-difluorophenyl)-N-(3,5-dimethylphenyl)-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(15) 1-(2,5-difluorophenyl)-N-(3,5-dimethylphenyl)-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(16) 1-(3,4-difluorophenyl)-N-(3,5-dimethyl phenyl)-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(17) 6-chloro-N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(18) N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-6-methoxy-1,9-dihydrospiro[β-carboline-4,1′-cyclopropane]-2(3H)-carboxamide,
(19) 2-acetyl-1-(3-fluorophenyl)-6,7-dimethoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(20) 2-acetyl-1-(2,4-difluorophenyl)-6,7-dimethoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(21) 2-acetyl-1-(2,4-difluorophenyl)-7-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(22) 2-acetyl-1-(3,4-difluorophenyl)-7-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(23) 2-acetyl-5-fluoro-1-(3-fluorophenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(24) 2-acetyl-1-(2,4-difluorophenyl)-5-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(25) 2-acetyl-1-(3,4-difluorophenyl)-5-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(26) 2-acetyl-1-(3-fluorophenyl)-8-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(27) 2-acetyl-1-(2,4-difluorophenyl)-8-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(28) 2-acetyl-1-(3,4-difluorophenyl)-8-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(29) 2-acetyl-1-(3-fluorophenyl)-6,8-dimethoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(30) 2-acetyl-1-(3,4-difluorophenyl)-6,8-dimethoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(31) 8-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-(3,5-dimethylphenyl)-5,6,8,9-tetrahydro-7H-pyrido[4′,3′:4,5]pyrrolo[2,3-b]pyridine-7-carboxamide,
(32) N-(3,5-dimethylphenyl)-8′-(3-fluorophenyl)-1′,8′-dihydrospiro[cyclopropane-1,5′-pyrido[4′,3′:4,5]pyrrolo[2,3-b]pyridine]-7′(6′H)-carboxamide,
(33) N-(3,5-dimethylphenyl)-8-(3-fluorophenyl)-9-methyl-5,6,8,9-tetrahydro-7H-pyrido[4′,3′:4,5]pyrrolo[2,3-b]pyridine-7-carboxamide,
(34) N-(3,5-dimethylphenyl)-8-(3-fluorophenyl)-1-methyl-1,5,6,8-tetrahydro-7H-pyrido[4′,3′:4,5]pyrrolo[2,3-b]pyridine-7-carboxamide,
(35) N-(3,5-dimethylphenyl)-6-(3-fluorophenyl)-5,6,8,9-tetrahydro-7H-pyrido[3′,4′:4,5]pyrrolo[2,3-c]pyridine-7-carboxamide,
(36) 7-acetyl-6-(3-fluorophenyl)-6,7,8,9-tetrahydro-5H-pyrido[3′,4′:4,5]pyrrolo[2,3-c]pyridine,
(37) N-(3,5-dimethylphenyl)-8′-(3-fluorophenyl)-1′-methyl-1′,8′-dihydrospiro[cyclopropane-1,5′-pyrido[4′,3′:4,5]pyrrolo[2,3-b]pyridine]-7′(6′H)-carboxamide,
(38) 7′-acetyl-8′-(3-fluorophenyl)-1′-methyl-1′,6′,7′,8′-tetrahydrospiro[cyclopropane-1,5′-pyrido[4′,3′:4,5]pyrrolo[2,3-b]pyridine,
(39) N-(3,5-dimethylphenyl)-8-(3-methoxyphenyl)-1-methyl-1,5,6,8-tetrahydro-7H-pyrido[4′,3′:4,5]pyrrolo[2,3-b]pyridine-7-carboxamide,
(40) 8-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-(3,5-dimethylphenyl)-1-methyl-1,5,6,8-tetrahydro-7H-pyrido[4′,3′:4,5]pyrrolo[2,3-b]pyridine-7-carboxamide,
(41) N-(3,5-dimethylphenyl)-6-(3-fluorophenyl)-2-methoxy-5,6,8,9-tetrahydro-7H-pyrido[4′,3′:4,5]pyrrolo[3,2-b]pyridine-7-carboxamide,
(42) 2-chloro-N-(3,5-dimethylphenyl)-6-(3-fluorophenyl)-5,6,8,9-tetrahydro-7H-pyrido[4′,3′:4,5]pyrrolo[3,2-b]pyridine-7-carboxamide,
(43) N-(3,5-dimethylphenyl)-6-(3-fluorophenyl)-5,6,8,9-tetrahydro-7H-pyrido[4′,3′:4,5]pyrrolo[3,2-b]pyridine-7-carboxamide,
(44) 7-acetyl-2-chloro-6-(3-fluorophenyl)-6,7,8,9-tetrahydro-5H-pyrido[4′,3′:4,5]pyrrolo[3,2-b]pyridine,
(45) 7-acetyl-6-(3-fluorophenyl)-6,7,8,9-tetrahydro-5H-pyrido[4′,3′:4,5]pyrrolo[3,2-b]pyridine,
(46) 2-ethyl-1-(3-fluorophenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(47) 2-acetyl-5-fluoro-1-(2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(48) 2-acetyl-5-methoxy-1-(2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane], or
(49) 4-(2-acetyl-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane]-1-yl)benzonitrile,
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 24 (depends on 13)

The compound according to claim 13, which is
(1) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(2) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(3) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-5,6-difluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(4) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-6-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(5) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(6) 2-acetyl-5-chloro-1-(4-chloro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(7) 2-acetyl-5-chloro-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(8) 2-acetyl-5-fluoro-1-(2-fluoro-6-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(9) 2-acetyl-6-fluoro-1-(4-fluoro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(10) 2-acetyl-5-fluoro-1-(4-fluoro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(11) 2-acetyl-1-(5-fluoro-2-methoxyphenyl)-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(12) 2-acetyl-1-(4-fluoro-2-methoxyphenyl)-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(13) 2-acetyl-1-(2,4-dimethoxyphenyl)-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane]
(14) 2-acetyl-1-(2-fluoro-6-methoxyphenyl)-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(15) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-6,7-dimethoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(16) 2-acetyl-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(17) 2-acetyl-5-fluoro-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(18) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-6-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(19) 2-acetyl-1-(4-fluoro-2-methoxyphenyl)-6-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(20) 2-acetyl-6-methoxy-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(21) 2-acetyl-1-(2-fluoro-6-methoxyphenyl)-6-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(22) 2-acetyl-6,7-dimethoxy-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(23) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-methyl-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(24) 2-acetyl-1-(2-methoxy-4-methylphenyl)-5-methyl-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(25) 2-acetyl-1-(2,3-dihydro-1-benzofuran-7-yl)-6-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(26) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-6-methoxy-5-methyl-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(27) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-5,6-dimethoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(28) (1S)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(29) (−)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-5,6-difluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(30) (+)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-5,6-difluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(31) (+)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(32) (+)-2-acetyl-1-(2-fluoro-6-methoxyphenyl)-5-methoxy-1,2,3,9-tetrahydrospiro[r3-carboline-4,1′-cyclopropane],
(33) (+)-2-acetyl-5-fluoro-1-(2-fluoro-6-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(34) (+)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-6,7-dimethoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane]
(35) 2-acetyl-5-chloro-1-(4-fluoro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(36) 2-acetyl-5,6-difluoro-1-(4-fluoro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(37) 2-acetyl-5,6-difluoro-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(38) 2-acetyl-5-chloro-1-(2-fluoro-6-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(39) 2-acetyl-1-(4-chloro-2-isopropoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(40) 2-acetyl-[4-chloro-2-(cyclopentyloxy)phenyl]-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(41) 4-(2-acetyl-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane]-1-yl)-3-methoxybenzonitrile,
(42) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-5,7-difluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(43) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-8-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(44) 4-(2-acetyl-5-fluoro-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane]-1-yl)-3-methoxybenzonitrile,
(45) 2-acetyl-5,6-dimethoxy-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(46) 2-acetyl-1-(2,3-dihydro-1-benzofuran-7-yl)-5-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(47) 2-acetyl-5-methoxy-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(48) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-6,8-dimethoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(49) 2-acetyl-6-chloro-1-(4-chloro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(50) 2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-fluoro-8-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(51) 2-acetyl-5-fluoro-1-(4-fluoro-2-methoxyphenyl)-8-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(52) (+)-2-acetyl-1-(2-fluoro-6-methoxyphenyl)-6-methoxy-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(53) (+)-2-acetyl-1-(2-methoxy-4-methylphenyl)-5-methyl-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(54) (+)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-6-methoxy-5-methyl-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(55) (+)-2-acetyl-5-fluoro-1-(4-fluoro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
(56) (+)-2-acetyl-5,6-difluoro-1-(2-methoxy-4-methylphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane], or
(57) (+)-2-acetyl-5-chloro-1-(4-chloro-2-methoxyphenyl)-1,2,3,9-tetrahydrospiro[β-carboline-4,1′-cyclopropane],
a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 25 (depends on 1)

A pharmaceutical composition comprising the compound represented by formula (I) described in claim 1, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof.

### Claim 26 (depends on 25)

The pharmaceutical composition according to claim 25, which is an agent for preventing and/or treating a disease caused by stress.

### Claim 27 (depends on 26)

The pharmaceutical composition according to claim 26, wherein the disease caused by stress is a digestive system disease caused by stress.

### Claim 28 (depends on 27)

The pharmaceutical composition according to claim 27, wherein the digestive system disease caused by stress is irritable bowel syndrome, ulcerative colitis, or Crohn's disease.

### Claim 29 (depends on 1)

A pharmaceutical composition comprising the compound represented by formula (I) described in claim 1, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof and one or more kind of agents selected from an antianxiety, an antidepressant, an anticholinergic, a gastrointestinal tract function regulator, a gastrointestinal tract prokinetic drug, an antidiarrheal, an evacuant, a calcium antagonist, a phosphodiesterase inhibitor and a serotonin antagonist in combination.

### Claim 30 (depends on 1)

A method for preventing and/or treating a disease caused by stress in a mammal comprising administering an effective amount of the compound represented by formula (I) described in claim 1, a salt thereof, an N-oxide, a solvate or a prodrug thereof to the mammal.
